Characterization of Chloride Transport Pathways in Cultured Human Keratinocytes
Overview
Biophysics
Authors
Affiliations
In human keratinocytes, mediated transport of Cl- was found to occur mainly by two mechanisms: an anion exchange and an electrically conductive pathway. The contribution of the anion exchange, which accounted for about 50% of overall Cl- efflux, was assessed either by its sensitivity to inhibition by 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), and by means of Cl- substitution experiments. The anion exchange exhibited a saturation behaviour over the range 10-135 mM Cl-; Cl- was more efficient than HCO3-, Br- and NO3- in increasing Cl- efflux rate, whereas SO4(2-) and I- inhibited Cl- efflux. The electrically conductive Cl- pathway, which accounted for about 40% of total Cl- efflux, was inhibited by the Cl- channel blocker 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) and was at least partially sensitive to variation of the plasma membrane potential. The Cl- channel was insensitive to elevation in the intracellular concentration of either cyclic AMP and calcium ions. Indomethacin, an inhibitor of the cyclooxygenase, failed to reduce Cl- efflux, whereas nordihydroguaiaretic acid (NDGA), an inhibitor of the lipoxygenase, induced 50% inhibition of Cl- efflux. These results support the conclusion that endogenous production of lipoxygenase-derived arachidonic acid metabolite(s) might be responsible for high basal Cl- permeability in human keratinocytes.
Modulated Start-Up Mode of Cancer Cell Migration Through Spinophilin-Tubular Networks.
Hwang S, Lee P, Shin D, Hong J Front Cell Dev Biol. 2021; 9:652791.
PMID: 33768098 PMC: 7985070. DOI: 10.3389/fcell.2021.652791.
Skin Absorption of Anions: Part One. Methodology for In Vitro Cutaneous Absorption Measurements.
Paweloszek R, Briancon S, Chevalier Y, Gilon-Delepine N, Pelletier J, Bolzinger M Pharm Res. 2016; 33(7):1564-75.
PMID: 27015843 DOI: 10.1007/s11095-016-1909-1.
Skin Absorption of Anions: Part Two. Skin Absorption of Halide Ions.
Paweloszek R, Briancon S, Chevalier Y, Gilon-Delepine N, Pelletier J, Bolzinger M Pharm Res. 2016; 33(7):1576-86.
PMID: 27001272 DOI: 10.1007/s11095-016-1898-0.
Zierler S, Yao G, Zhang Z, Kuo W, Porzgen P, Penner R J Biol Chem. 2011; 286(45):39328-35.
PMID: 21926172 PMC: 3234757. DOI: 10.1074/jbc.M111.264341.
Koizumi S, Fujishita K, Inoue K, Shigemoto-Mogami Y, Tsuda M, Inoue K Biochem J. 2004; 380(Pt 2):329-38.
PMID: 14967069 PMC: 1224173. DOI: 10.1042/BJ20031089.